Richmond Pharmacology is proud to announce its participation in TheLiver Meeting 2024, hosted by the American Association for the Study of LiverDiseases (AASLD). This event gathers leading hepatology experts to discussgroundbreaking research and advancements in liver diseases. The conference willfeature a wide range of sessions, including state-of-the-art lectures,workshops, and networking opportunities.

To connect with our team during the event, please reach out to arrange ameeting.

For more information, visit the AASLD Liver Meeting 2024 website.

Latest news

Richmond Appoints Lisa Campbell as Director of Regulatory Strategy

April 23, 2025
Richmond Pharmacology is pleased to announce the appointment of Lisa Campbell as Director of Regulatory Strategy
Read more

Von Willebrand Disease Trial – First Stage of Hemab Therapeutics’ Trial Completed and New Patients Invited to Enrol

April 2, 2025
Richmond has completed dosing the first cohort of patients in Velora Pioneer, a phase 1/2 clinical trial investigating Hemab...
Read more

Events

BIO International Convention 2025

16-19 June 2025
Richmond Pharmacology will be attending the BIO International Convention 2025 in Boston, connecting with biotech innovators at Booth 765.
View event